Spot scanning proton therapy plan assessment: design and development of a dose verification application for use in routine clinical practice

2016 ◽  
Author(s):  
Kurt E. Augustine ◽  
Timothy J. Walsh ◽  
Chris J. Beltran ◽  
Joshua B. Stoker ◽  
Daniel W. Mundy ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Proton Therapy ◽  
Routine Clinical Practice ◽  
Dose Verification ◽  
Design And Development ◽  
Assessment Design ◽  
Spot Scanning

SU-E-T-52: Independent Dose Verification System for Spot Scanning Proton Therapy

2012 ◽  
Vol 39 (6Part10) ◽  
pp. 3714-3714
Author(s):  
Y Li ◽  
M Lii ◽  
H Li ◽  
M Taylor ◽  
X Li ◽  
...  
Keyword(s):  
Proton Therapy ◽  
Dose Verification ◽  
Spot Scanning ◽  
Verification System

scholarly journals National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

2021 ◽  
Vol 8 (1) ◽  
pp. 354-365
Author(s):  
Johannes A. Langendijk ◽  
Frank J. P. Hoebers ◽  
Martin A. de Jong ◽  
Patricia Doornaert ◽  
Chris H. J. Terhaard ◽  
...  
Keyword(s):  
Health Care ◽  
Head And Neck Cancer ◽  
Clinical Practice ◽  
Head And Neck ◽  
Neck Cancer ◽  
Proton Therapy ◽  
Routine Clinical Practice ◽  
Model Based ◽  
Radiation Induced ◽  
Selection For

Abstract In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Diagnosis and Management of Cardiomyopathies – A Focus on Genetics, Cardiac Magnetic Resonance and Clinical Features

2011 ◽  
Vol 7 (3) ◽  
pp. 225
Author(s):  
Gianfranco Sinagra ◽  
Michele Moretti ◽  
Giancarlo Vitrella ◽  
Marco Merlo ◽  
Rossana Bussani ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Imaging Techniques ◽  
Molecular Genetic ◽  
Molecular Genetic Analysis ◽  
Routine Clinical Practice ◽  
Clinical Approach ◽  
Diagnosis And Management ◽  
Made In

In recent years, outstanding progress has been made in the diagnosis and treatment of cardiomyopathies. Genetics is emerging as a primary point in the diagnosis and management of these diseases. However, molecular genetic analyses are not yet included in routine clinical practice, mainly because of their elevated costs and execution time. A patient-based and patient-oriented clinical approach, coupled with new imaging techniques such as cardiac magnetic resonance, can be of great help in selecting patients for molecular genetic analysis and is crucial for a better characterisation of these diseases. This article will specifically address clinical, magnetic resonance and genetic aspects of the diagnosis and management of cardiomyopathies.

Sign in / Sign up

Export Citation Format

Share Document